Posterior reversible encephalopathy syndrome: a case report

Authors

  • Asna Aafreen Department of obstetrics and gynecology, Massachusetts, USA
  • Apoorv Pankaj Department of obstetrics and gynecology, Lucknow, UP, India
  • Aprajita Pankaj Reproductive Medicine and Surgery, Lucknow, UP, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20222502

Keywords:

PRES syndrome, Neurological, Antenatal, Edema

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a neurotoxic syndrome that is characterised by neurological symptoms and radiological features. The symptoms include vomiting, headache, seizures, variable loss of eyesight and loss of consciousness. Imaging studies show white mater abnormalities and edema. Management includes control of blood pressure and prevention of seizures along with timely delivery. Some patients might require ICU admission and a multidisciplinary team management. The condition has a good prognosis if timely management is instituted. Here we present a case report on PRES syndrome.

 

Author Biography

Aprajita Pankaj, Reproductive Medicine and Surgery, Lucknow, UP, India

Obstetrics and Gynaecology

References

Poma S, Delmonte MP, Gigliuto C, Imberti R, Delmonte M, Arossa A et al. Management of posterior reversible syndrome in preeclamptic women. Case Rep Obstetr Gynecol. 2014;2014.

Parasher A, Jhamb R. Posterior reversible encephalopathy syndrome (PRES): presentation, diagnosis and treatment. Postgraduate Med J. 2020;96(1140):623-8.

Onder AM, Lopez R, Teomete U, Francoeur D, Bhatia R, Knowbi O et al. Posterior reversible encephalopathy syndrome in the pediatric renal population. Pediatric Nephrology. 2007 Nov;22(11):1921-9.

McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS, SantaCruz KS et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. Am J Roentgenol. 2007;189(4):904-12.

Hinduja A. Posterior reversible encephalopathy syndrome: clinical features and outcome. Frontiers Neurol. 2020;11:71.

Fujiwara Y, Higaki H, Yamada T, Nakata Y, Kato S, Yamamoto H et al. Two cases of reversible posterior leukoencephalopathy syndrome, one with and the other without pre‐eclampsia. J Obstetr Gynaecol Res. 2005;31(6):520-6.

Legriel S, Schraub O, Azoulay E, Hantson P, Magalhaes E, Coquet I et al. Critically III Posterior Reversible Encephalopathy Syndrome Study Group (CYPRESS). Determinants of recovery from severe posterior reversible encephalopathy syndrome. PLoS One. 2012;7(9):e44534.

Alhilali LM, Reynolds AR, Fakhran S. A multi-disciplinary model of risk factors for fatal outcome in posterior reversible encephalopathy syndrome. J Neurolog Sci. 2014;347(1-2):59-65.

Sudulagunta SR, Sodalagunta MB, Kumbhat M, Settikere Nataraju A. Posterior reversible encephalopathy syndrome (PRES). Oxford Med Case Rep. 2017;2017(4).

Gao B, Lyu C, Lerner A, McKinney AM. Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years? J Neurol Neurosurg Psychiatr. 2018;89(1):14-20.

Largeau B, Le Tilly O, Sautenet B, Salmon Gandonnière C, Guellec BL, Ehrmann S. Arginine vasopressin and posterior reversible encephalopathy syndrome pathophysiology: the missing link? Mol Neurobiol. 2019;56(10):6792-806.

Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. Am J Neuroradiol. 2007;28(7):1320-7.

American College of Obstetricians and Gynecologists. ACOG practice bulletin. Obstetric analgesia and anesthesia. Int J Gynaecol Obstetr. 2002;78(3):321-35.

Downloads

Published

2022-09-27

Issue

Section

Case Reports